Quantum Genomics (STU:2QG) Cash-to-Debt : 3.43 (As of Dec. 2022)

Quantum Genomics Cash-to-Debt Chart

Quantum Genomics Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Cash-to-Debt		Get a 7-Day Free Trial					7,398.50	11,164.00	13,576.50	4.51	3.43

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Cash-to-Debt	Get a 7-Day Free Trial															13,576.50	8.28	4.51	5.77	3.43

Competitive Comparison of Quantum Genomics's Cash-to-Debt

For the Biotechnology subindustry, Quantum Genomics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quantum Genomics's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's Cash-to-Debt falls into.

Quantum Genomics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Quantum Genomics's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Quantum Genomics's Cash to Debt Ratio for the quarter that ended in Dec. 2022 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum Genomics  (STU:2QG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Quantum Genomics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (STU:2QG) Business Description